Shakeel Kahn, Petitioner v. United States

  1. March 01, 2022

    High Court Poised To Make DOJ's Job Harder In Opioid Cases

    The U.S. Supreme Court appeared likely Tuesday to demand stronger proof of intentional wrongdoing when the U.S. Department of Justice prosecutes opioid prescribers, according to experts, an outcome that might also help major pharmacy chains accused of recklessly selling narcotic painkillers.

  2. February 25, 2022

    DOJ Has Few Allies, Many Foes In High Court Opioid Brawl

    It seemed like a marquee win for the U.S. Department of Justice: The felony conviction of an Alabama doctor who prescribed fentanyl in quantities so immense he may have influenced a drugmaker's stock price. But as U.S. Supreme Court justices are set to scrutinize the conviction on Tuesday, numerous scholars and corporate groups are calling it ominous and unfair, with virtually no one backing the DOJ.

  3. January 20, 2022

    Feds Urge High Court To Back Doctors' Opioid Convictions

    The federal government has urged the U.S. Supreme Court to ignore requests from two doctors who want the justices to undo their convictions over charges related to allegedly improper prescriptions of controlled substances.

  4. November 22, 2021

    DOJ-Walmart Opioid Battle Halted As High Court Reviews CSA

    The U.S. Department of Justice's sweeping lawsuit contending that Walmart's 5,000 pharmacies "helped fuel a national crisis" of opioid abuse is being halted until the U.S. Supreme Court decides newly accepted cases involving the boundaries of Controlled Substances Act enforcement, a Delaware federal judge ruled.